Cancer Virotherapy and Immunotherapy


The Cancer Virotherapy and Immunotherapy Group explores new anticancer treatments based on oncolytic adenoviruses and other immunotherapies. The group aims to design and evaluate oncolytic adenoviruses as antitumour agents for various solid tumours. The main lines of research are tumour targets, intratumoural diffusion through stromal barriers and oncolytic immunotherapy. The group also participates in other immunotherapy projects based on mutanome-derived cancer neoepitopes and cellular immunotherapy with modified NK cells.  



Alemany Bonastre, Ramon

Alemany Bonastre, Ramon

Principal investigators


Group leaders
  • Alemany Bonastre, Ramón
Postdoctoral researchers (R2)
Predoctoral researchers (R1)
Scientific support
Scroll to Top